Sgadari C - Search Results

1

Pharmacological management of Kaposi's sarcoma.

Sgadari C, Bacigalupo I, Barillari G, Ensoli B. Sgadari C, et al. Expert Opin Pharmacother. 2011 Aug;12(11):1669-90. doi: 10.1517/14656566.2011.577066. Epub 2011 Apr 25. Expert Opin Pharmacother. 2011. PMID: 21517697 Review.

2

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.

Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S, Palladino C, Leone P, Bugarini R, Malavasi L, Cafaro A, Falchi M, Valdembri D, Rezza G, Bussolino F, Monini P, Ensoli B. Sgadari C, et al. Nat Med. 2002 Mar;8(3):225-32. doi: 10.1038/nm0302-225. Nat Med. 2002. PMID: 11875492

3

Treatment of Kaposi's sarcoma--an update.

Toschi E, Sgadari C, Monini P, Barillari G, Bacigalupo I, Palladino C, Baccarini S, Carlei D, Grosso G, Sirianni MC, Ensoli B. Toschi E, et al. Among authors: sgadari c. Anticancer Drugs. 2002 Nov;13(10):977-87. doi: 10.1097/00001813-200211000-00001. Anticancer Drugs. 2002. PMID: 12439331 Review.

4

[HIV protease inhibitors for the treatment of Kaposi's sarcoma].

Grosso G, Sgadari C, Barillari G, Toschi E, Bacigalupo I, Carlei D, Palladino C, Baccarini S, Malavasi L, Moracci G, Leone P, Chiozzini C, Monini P, Ensoli B. Grosso G, et al. Among authors: sgadari c. Recenti Prog Med. 2003 Feb;94(2):69-74. Recenti Prog Med. 2003. PMID: 12908373 Review. Italian.

5

HIV protease inhibitors as new treatment options for Kaposi's sarcoma.

Barillari G, Sgadari C, Toschi E, Monini P, Ensoli B. Barillari G, et al. Among authors: sgadari c. Drug Resist Updat. 2003 Aug;6(4):173-81. doi: 10.1016/s1368-7646(03)00060-8. Drug Resist Updat. 2003. PMID: 12962683

6

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth.

Sgadari C, Monini P, Barillari G, Ensoli B. Sgadari C, et al. Lancet Oncol. 2003 Sep;4(9):537-47. doi: 10.1016/s1470-2045(03)01192-6. Lancet Oncol. 2003. PMID: 12965274 Review.

7

Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.

Monini P, Sgadari C, Grosso MG, Bellino S, Di Biagio A, Toschi E, Bacigalupo I, Sabbatucci M, Cencioni G, Salvi E, Leone P, Ensoli B. Monini P, et al. Among authors: sgadari c. AIDS. 2009 Feb 20;23(4):534-8. doi: 10.1097/QAD.0b013e3283262a8d. AIDS. 2009. PMID: 19169139 Clinical Trial.

8

Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma.

Sgadari C, Barillari G, Palladino C, Bellino S, Taddeo B, Toschi E, Ensoli B. Sgadari C, et al. Int J Vasc Med. 2011;2011:452729. doi: 10.1155/2011/452729. Epub 2011 Oct 9. Int J Vasc Med. 2011. PMID: 22007303 Free PMC article.

9

Kaposi's Sarcoma Lesion Progression in BKV-Tat Transgenic Mice Is Increased by Inflammatory Cytokines and Blocked by Treatment with Anti-Tat Antibodies.

Brocca-Cofano E, Sgadari C, Picconi O, Palladino C, Caputo A, Ensoli B. Brocca-Cofano E, et al. Among authors: sgadari c. Int J Mol Sci. 2022 Feb 14;23(4):2081. doi: 10.3390/ijms23042081. Int J Mol Sci. 2022. PMID: 35216197 Free PMC article.

10

Mechanism of paclitaxel activity in Kaposi's sarcoma.

Sgadari C, Toschi E, Palladino C, Barillari G, Carlei D, Cereseto A, Ciccolella C, Yarchoan R, Monini P, Stürzl M, Ensoli B. Sgadari C, et al. J Immunol. 2000 Jul 1;165(1):509-17. doi: 10.4049/jimmunol.165.1.509. J Immunol. 2000. PMID: 10861090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page